Rank | Gene Set | Z-score |
---|---|---|
1 | protein maturation by protein folding (GO:0022417) | 7.56254360 |
2 | establishment of viral latency (GO:0019043) | 6.50330742 |
3 | establishment of integrated proviral latency (GO:0075713) | 6.22020205 |
4 | fusion of sperm to egg plasma membrane (GO:0007342) | 5.93808637 |
5 | extracellular fibril organization (GO:0043206) | 5.45073629 |
6 | proteasome assembly (GO:0043248) | 5.00087208 |
7 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 4.75603862 |
8 | positive regulation of actin filament depolymerization (GO:0030836) | 4.70496814 |
9 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 4.48758486 |
10 | fibril organization (GO:0097435) | 4.42648830 |
11 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.40755145 |
12 | plasma membrane fusion (GO:0045026) | 4.38671725 |
13 | sequestering of actin monomers (GO:0042989) | 4.24824581 |
14 | ATP synthesis coupled proton transport (GO:0015986) | 4.06892295 |
15 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.06892295 |
16 | nuclear envelope reassembly (GO:0031468) | 3.97650629 |
17 | mitotic nuclear envelope reassembly (GO:0007084) | 3.97650629 |
18 | response to gravity (GO:0009629) | 3.92772419 |
19 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 3.92287327 |
20 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.91852999 |
21 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.91852999 |
22 | respiratory electron transport chain (GO:0022904) | 3.85187275 |
23 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.81834104 |
24 | pattern specification involved in kidney development (GO:0061004) | 3.76485542 |
25 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.75868011 |
26 | electron transport chain (GO:0022900) | 3.74926540 |
27 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.74620167 |
28 | regulation of metalloenzyme activity (GO:0048552) | 3.72303717 |
29 | DNA unwinding involved in DNA replication (GO:0006268) | 3.69136119 |
30 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.64491771 |
31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.63618212 |
32 | actin filament depolymerization (GO:0030042) | 3.57034495 |
33 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.52447913 |
34 | morphogenesis of an endothelium (GO:0003159) | 3.52364311 |
35 | endothelial tube morphogenesis (GO:0061154) | 3.52364311 |
36 | response to interferon-beta (GO:0035456) | 3.50874076 |
37 | muscle cell migration (GO:0014812) | 3.50363257 |
38 | chromosome condensation (GO:0030261) | 3.49821310 |
39 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.49722191 |
40 | negative regulation of ligase activity (GO:0051352) | 3.49722191 |
41 | DNA packaging (GO:0006323) | 3.46549093 |
42 | regulation of mitochondrial translation (GO:0070129) | 3.45178717 |
43 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.45125772 |
44 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.45088751 |
45 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.44559955 |
46 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.41564226 |
47 | regulation of cilium movement (GO:0003352) | 3.39055214 |
48 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.38779634 |
49 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.38409838 |
50 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.36082406 |
51 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.36082406 |
52 | protein retention in ER lumen (GO:0006621) | 3.34761324 |
53 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.30131066 |
54 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.30131066 |
55 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.30131066 |
56 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.30048923 |
57 | galactose catabolic process (GO:0019388) | 3.29851861 |
58 | type B pancreatic cell proliferation (GO:0044342) | 3.28286501 |
59 | protein complex biogenesis (GO:0070271) | 3.28280319 |
60 | acrosome reaction (GO:0007340) | 3.22468315 |
61 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.20240902 |
62 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.20240902 |
63 | sperm motility (GO:0030317) | 3.19888257 |
64 | viral protein processing (GO:0019082) | 3.16658649 |
65 | gonadal mesoderm development (GO:0007506) | 3.14677334 |
66 | multicellular organism reproduction (GO:0032504) | 3.13897993 |
67 | ribosome assembly (GO:0042255) | 3.13033458 |
68 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.12950978 |
69 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.12806137 |
70 | chaperone-mediated protein transport (GO:0072321) | 3.10610870 |
71 | membrane raft organization (GO:0031579) | 3.08862039 |
72 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.08188288 |
73 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.06498863 |
74 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.05928030 |
75 | cellular response to zinc ion (GO:0071294) | 3.05667527 |
76 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.05333633 |
77 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.05333633 |
78 | cellular copper ion homeostasis (GO:0006878) | 3.03988377 |
79 | rRNA modification (GO:0000154) | 2.99554493 |
80 | spermatid development (GO:0007286) | 2.99159116 |
81 | virion assembly (GO:0019068) | 2.98328960 |
82 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.95242317 |
83 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.95239835 |
84 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.94316272 |
85 | ribosomal large subunit biogenesis (GO:0042273) | 2.90702155 |
86 | positive regulation of ligase activity (GO:0051351) | 2.90013003 |
87 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.87662807 |
88 | positive regulation of mitochondrial fission (GO:0090141) | 2.86136008 |
89 | cullin deneddylation (GO:0010388) | 2.83746945 |
90 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.83089096 |
91 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.78870150 |
92 | reproduction (GO:0000003) | 2.77693905 |
93 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.77495879 |
94 | regulation of gonadotropin secretion (GO:0032276) | 2.76911951 |
95 | glomerular visceral epithelial cell development (GO:0072015) | 2.76114391 |
96 | mesonephros development (GO:0001823) | 2.75402354 |
97 | NADH dehydrogenase complex assembly (GO:0010257) | 2.74992692 |
98 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.74992692 |
99 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.74992692 |
100 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.73702032 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.89552159 |
2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.92898869 |
3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.69944627 |
4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.02893191 |
5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.00994791 |
6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.98324765 |
7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.81385682 |
8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.72164584 |
9 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.63217251 |
10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.55558081 |
11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.54514578 |
12 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 2.49285344 |
13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.47971100 |
14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.41344847 |
15 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.36851795 |
16 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.36269202 |
17 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.33786704 |
18 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.32936476 |
19 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.28916680 |
20 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.26229262 |
21 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.18081935 |
22 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.10226459 |
23 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.08340059 |
24 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.05626276 |
25 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.99230776 |
26 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.94673879 |
27 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.94293933 |
28 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.83516916 |
29 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.77305529 |
30 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.75921517 |
31 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.73146314 |
32 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.68088594 |
33 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.67228686 |
34 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.65176824 |
35 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.63064479 |
36 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.61018357 |
37 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.59830968 |
38 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.57766011 |
39 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55679223 |
40 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.55104105 |
41 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.52861633 |
42 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.52160908 |
43 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51831198 |
44 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.50026751 |
45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48820252 |
46 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.47687936 |
47 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.46362850 |
48 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.43297916 |
49 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.40542422 |
50 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.37424081 |
51 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.37067562 |
52 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.36431514 |
53 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.36364720 |
54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35900055 |
55 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.35271131 |
56 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35264145 |
57 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.35100877 |
58 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.32743469 |
59 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.31859687 |
60 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.31820624 |
61 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.31760399 |
62 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.31745390 |
63 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.30327689 |
64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30064262 |
65 | ATF3_27146783_Chip-Seq_COLON_Human | 1.27874775 |
66 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.27215097 |
67 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.23617500 |
68 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.22460575 |
69 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.22277208 |
70 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.17906733 |
71 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.17492128 |
72 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16480551 |
73 | P300_27268052_Chip-Seq_Bcells_Human | 1.14996090 |
74 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.14915103 |
75 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.14907772 |
76 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.14339428 |
77 | P68_20966046_ChIP-Seq_HELA_Human | 1.13305110 |
78 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.12689074 |
79 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11813263 |
80 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.10970149 |
81 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10735829 |
82 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.10000537 |
83 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.07691756 |
84 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.06838480 |
85 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.05014755 |
86 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.03608082 |
87 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.02633795 |
88 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.02547865 |
89 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.00775834 |
90 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00158341 |
91 | CBP_21632823_ChIP-Seq_H3396_Human | 1.00001524 |
92 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.99865342 |
93 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.99285433 |
94 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.97833233 |
95 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.97833233 |
96 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97314943 |
97 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.96586479 |
98 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.95350321 |
99 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.93884134 |
100 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92374452 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005410_abnormal_fertilization | 5.04754317 |
2 | MP0005670_abnormal_white_adipose | 3.55947303 |
3 | MP0003123_paternal_imprinting | 3.50312141 |
4 | MP0000516_abnormal_urinary_system | 3.38598590 |
5 | MP0005367_renal/urinary_system_phenotyp | 3.38598590 |
6 | MP0004510_myositis | 3.36306488 |
7 | MP0003191_abnormal_cellular_cholesterol | 3.31743481 |
8 | MP0003806_abnormal_nucleotide_metabolis | 3.30228997 |
9 | MP0010030_abnormal_orbit_morphology | 2.90023356 |
10 | MP0000749_muscle_degeneration | 2.77918055 |
11 | MP0005257_abnormal_intraocular_pressure | 2.75701436 |
12 | MP0002837_dystrophic_cardiac_calcinosis | 2.65717995 |
13 | MP0000751_myopathy | 2.63519480 |
14 | MP0000750_abnormal_muscle_regeneration | 2.56566568 |
15 | MP0003950_abnormal_plasma_membrane | 2.46778526 |
16 | MP0005165_increased_susceptibility_to | 2.34621477 |
17 | MP0009697_abnormal_copulation | 2.33824830 |
18 | MP0002332_abnormal_exercise_endurance | 2.30468390 |
19 | MP0001542_abnormal_bone_strength | 2.19938235 |
20 | MP0002877_abnormal_melanocyte_morpholog | 2.04382508 |
21 | MP0001853_heart_inflammation | 2.03646067 |
22 | MP0003786_premature_aging | 2.01390715 |
23 | MP0008775_abnormal_heart_ventricle | 1.94193701 |
24 | MP0000343_altered_response_to | 1.91412310 |
25 | MP0003186_abnormal_redox_activity | 1.78016807 |
26 | MP0003075_altered_response_to | 1.77317857 |
27 | MP0003315_abnormal_perineum_morphology | 1.74795327 |
28 | MP0004272_abnormal_basement_membrane | 1.64411577 |
29 | MP0005360_urolithiasis | 1.58675847 |
30 | MP0006036_abnormal_mitochondrial_physio | 1.56786661 |
31 | MP0003718_maternal_effect | 1.53901241 |
32 | MP0008438_abnormal_cutaneous_collagen | 1.48683043 |
33 | MP0005330_cardiomyopathy | 1.47619428 |
34 | MP0002282_abnormal_trachea_morphology | 1.46374116 |
35 | MP0009764_decreased_sensitivity_to | 1.42176974 |
36 | MP0005058_abnormal_lysosome_morphology | 1.39175390 |
37 | MP0000534_abnormal_ureter_morphology | 1.37210622 |
38 | MP0003566_abnormal_cell_adhesion | 1.36966051 |
39 | MP0001929_abnormal_gametogenesis | 1.34117108 |
40 | MP0001905_abnormal_dopamine_level | 1.32445838 |
41 | MP0001299_abnormal_eye_distance/ | 1.32384121 |
42 | MP0006054_spinal_hemorrhage | 1.27010218 |
43 | MP0003698_abnormal_male_reproductive | 1.22884841 |
44 | MP0002163_abnormal_gland_morphology | 1.22762246 |
45 | MP0002653_abnormal_ependyma_morphology | 1.22628256 |
46 | MP0000858_altered_metastatic_potential | 1.17650710 |
47 | MP0009053_abnormal_anal_canal | 1.17326343 |
48 | MP0005166_decreased_susceptibility_to | 1.16239017 |
49 | MP0002060_abnormal_skin_morphology | 1.15022880 |
50 | MP0003638_abnormal_response/metabolism_ | 1.13200721 |
51 | MP0004957_abnormal_blastocyst_morpholog | 1.10679771 |
52 | MP0003077_abnormal_cell_cycle | 1.08455749 |
53 | MP0005408_hypopigmentation | 1.06786116 |
54 | MP0009840_abnormal_foam_cell | 1.05137135 |
55 | MP0003646_muscle_fatigue | 1.04894091 |
56 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03709909 |
57 | MP0008789_abnormal_olfactory_epithelium | 1.01082728 |
58 | MP0005266_abnormal_metabolism | 1.00938097 |
59 | MP0001346_abnormal_lacrimal_gland | 0.97138009 |
60 | MP0009379_abnormal_foot_pigmentation | 0.94190064 |
61 | MP0002972_abnormal_cardiac_muscle | 0.93004182 |
62 | MP0008007_abnormal_cellular_replicative | 0.92477325 |
63 | MP0003121_genomic_imprinting | 0.91652267 |
64 | MP0003279_aneurysm | 0.91460457 |
65 | MP0005379_endocrine/exocrine_gland_phen | 0.91362362 |
66 | MP0003329_amyloid_beta_deposits | 0.90211972 |
67 | MP0005464_abnormal_platelet_physiology | 0.88723896 |
68 | MP0000358_abnormal_cell_content/ | 0.87851843 |
69 | MP0004147_increased_porphyrin_level | 0.87635224 |
70 | MP0001243_abnormal_dermal_layer | 0.87505666 |
71 | MP0002177_abnormal_outer_ear | 0.84240502 |
72 | MP0009333_abnormal_splenocyte_physiolog | 0.82907387 |
73 | MP0000249_abnormal_blood_vessel | 0.80515312 |
74 | MP0005197_abnormal_uvea_morphology | 0.78134988 |
75 | MP0002161_abnormal_fertility/fecundity | 0.75387289 |
76 | MP0002106_abnormal_muscle_physiology | 0.72930762 |
77 | MP0001727_abnormal_embryo_implantation | 0.72469808 |
78 | MP0003011_delayed_dark_adaptation | 0.71752289 |
79 | MP0002210_abnormal_sex_determination | 0.71641106 |
80 | MP0003436_decreased_susceptibility_to | 0.71518606 |
81 | MP0001879_abnormal_lymphatic_vessel | 0.71192228 |
82 | MP0010368_abnormal_lymphatic_system | 0.70181087 |
83 | MP0002019_abnormal_tumor_incidence | 0.69772405 |
84 | MP0000647_abnormal_sebaceous_gland | 0.68968647 |
85 | MP0001756_abnormal_urination | 0.66136383 |
86 | MP0005083_abnormal_biliary_tract | 0.65452813 |
87 | MP0000613_abnormal_salivary_gland | 0.64155948 |
88 | MP0000639_abnormal_adrenal_gland | 0.63806177 |
89 | MP0000372_irregular_coat_pigmentation | 0.63735544 |
90 | MP0000762_abnormal_tongue_morphology | 0.62040501 |
91 | MP0005164_abnormal_response_to | 0.60701206 |
92 | MP0005376_homeostasis/metabolism_phenot | 0.59970007 |
93 | MP0001340_abnormal_eyelid_morphology | 0.59421141 |
94 | MP0001835_abnormal_antigen_presentation | 0.58013425 |
95 | MP0005395_other_phenotype | 0.57685751 |
96 | MP0002006_tumorigenesis | 0.57257372 |
97 | MP0002132_abnormal_respiratory_system | 0.56314402 |
98 | MP0008469_abnormal_protein_level | 0.54248642 |
99 | MP0000313_abnormal_cell_death | 0.53371807 |
100 | MP0006035_abnormal_mitochondrial_morpho | 0.52750592 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hepatocellular necrosis (HP:0001404) | 5.15599201 |
2 | Amyloidosis (HP:0011034) | 4.80996491 |
3 | Mitochondrial inheritance (HP:0001427) | 4.73997807 |
4 | Hepatic necrosis (HP:0002605) | 4.45856842 |
5 | Acute necrotizing encephalopathy (HP:0006965) | 4.43832782 |
6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.15810428 |
7 | Glucose intolerance (HP:0000833) | 4.02297960 |
8 | Renal Fanconi syndrome (HP:0001994) | 3.88410227 |
9 | Increased CSF lactate (HP:0002490) | 3.87385557 |
10 | Delayed CNS myelination (HP:0002188) | 3.82114635 |
11 | Acute encephalopathy (HP:0006846) | 3.66614960 |
12 | Congenital, generalized hypertrichosis (HP:0004540) | 3.65741015 |
13 | Progressive macrocephaly (HP:0004481) | 3.58485009 |
14 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.52619866 |
15 | Upper limb muscle weakness (HP:0003484) | 3.41043671 |
16 | Increased hepatocellular lipid droplets (HP:0006565) | 3.37937560 |
17 | Adrenal hypoplasia (HP:0000835) | 3.29765563 |
18 | Exertional dyspnea (HP:0002875) | 3.12999984 |
19 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.10159871 |
20 | Vertebral compression fractures (HP:0002953) | 3.08521088 |
21 | Distal lower limb muscle weakness (HP:0009053) | 3.08420950 |
22 | Microglossia (HP:0000171) | 3.07981139 |
23 | Severe visual impairment (HP:0001141) | 2.99037577 |
24 | Premature rupture of membranes (HP:0001788) | 2.91324658 |
25 | Osteolytic defects of the hand bones (HP:0009699) | 2.84211819 |
26 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.84211819 |
27 | Male infertility (HP:0003251) | 2.82066484 |
28 | Axonal loss (HP:0003447) | 2.81773465 |
29 | Type I transferrin isoform profile (HP:0003642) | 2.79772100 |
30 | Abnormal spermatogenesis (HP:0008669) | 2.74772136 |
31 | Increased intramyocellular lipid droplets (HP:0012240) | 2.73182316 |
32 | Lipid accumulation in hepatocytes (HP:0006561) | 2.69669168 |
33 | Insulin resistance (HP:0000855) | 2.68233921 |
34 | Vascular calcification (HP:0004934) | 2.65466210 |
35 | Exercise intolerance (HP:0003546) | 2.62256560 |
36 | Entropion (HP:0000621) | 2.61347400 |
37 | Emotional lability (HP:0000712) | 2.58664331 |
38 | Respiratory failure (HP:0002878) | 2.54735544 |
39 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.53884318 |
40 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.53884318 |
41 | Flat capital femoral epiphysis (HP:0003370) | 2.53379180 |
42 | Short nail (HP:0001799) | 2.50176914 |
43 | Prolonged neonatal jaundice (HP:0006579) | 2.47547151 |
44 | Natal tooth (HP:0000695) | 2.45599463 |
45 | Cerebral edema (HP:0002181) | 2.43821124 |
46 | Abnormal glucose tolerance (HP:0001952) | 2.43122879 |
47 | Lactic acidosis (HP:0003128) | 2.41556746 |
48 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.40931035 |
49 | Hepatosplenomegaly (HP:0001433) | 2.39544735 |
50 | Spastic paraparesis (HP:0002313) | 2.34796043 |
51 | Increased serum lactate (HP:0002151) | 2.34744400 |
52 | Abnormality of placental membranes (HP:0011409) | 2.32830594 |
53 | Amniotic constriction ring (HP:0009775) | 2.32830594 |
54 | Cardiovascular calcification (HP:0011915) | 2.31847819 |
55 | Bifid uvula (HP:0000193) | 2.26956238 |
56 | Cholecystitis (HP:0001082) | 2.26438573 |
57 | Abnormal gallbladder physiology (HP:0012438) | 2.26438573 |
58 | Opisthotonus (HP:0002179) | 2.26393309 |
59 | Rough bone trabeculation (HP:0100670) | 2.25595723 |
60 | Increased serum pyruvate (HP:0003542) | 2.23580510 |
61 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.22363448 |
62 | Hand muscle atrophy (HP:0009130) | 2.22043542 |
63 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.20920058 |
64 | Abnormality of renal resorption (HP:0011038) | 2.20881861 |
65 | Increased muscle lipid content (HP:0009058) | 2.18397873 |
66 | Facial cleft (HP:0002006) | 2.16326648 |
67 | Hypertriglyceridemia (HP:0002155) | 2.14680707 |
68 | Abnormality of the anterior horn cell (HP:0006802) | 2.12730828 |
69 | Degeneration of anterior horn cells (HP:0002398) | 2.12730828 |
70 | CNS demyelination (HP:0007305) | 2.12576997 |
71 | Sparse eyelashes (HP:0000653) | 2.12521287 |
72 | Abnormality of glycolysis (HP:0004366) | 2.10558860 |
73 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.10042463 |
74 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.10042463 |
75 | Abnormal protein glycosylation (HP:0012346) | 2.10042463 |
76 | Abnormal glycosylation (HP:0012345) | 2.10042463 |
77 | Sclerocornea (HP:0000647) | 2.08761537 |
78 | Atrophic scars (HP:0001075) | 2.06241162 |
79 | Orthostatic hypotension (HP:0001278) | 2.04839837 |
80 | Optic disc pallor (HP:0000543) | 2.04614796 |
81 | Difficulty climbing stairs (HP:0003551) | 2.03196021 |
82 | Vacuolated lymphocytes (HP:0001922) | 2.02331148 |
83 | Respiratory difficulties (HP:0002880) | 1.99148914 |
84 | Joint hemorrhage (HP:0005261) | 1.98899794 |
85 | Distal lower limb amyotrophy (HP:0008944) | 1.94125334 |
86 | Gliosis (HP:0002171) | 1.92325941 |
87 | Reduced antithrombin III activity (HP:0001976) | 1.92272337 |
88 | Acanthosis nigricans (HP:0000956) | 1.89397616 |
89 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.88597220 |
90 | Muscle stiffness (HP:0003552) | 1.88510032 |
91 | Hypoalphalipoproteinemia (HP:0003233) | 1.87297418 |
92 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.86948519 |
93 | X-linked dominant inheritance (HP:0001423) | 1.86851394 |
94 | Leukodystrophy (HP:0002415) | 1.86162847 |
95 | Myocardial infarction (HP:0001658) | 1.84364860 |
96 | Retinal dysplasia (HP:0007973) | 1.84086529 |
97 | Down-sloping shoulders (HP:0200021) | 1.82413545 |
98 | Bradycardia (HP:0001662) | 1.82160231 |
99 | Generalized aminoaciduria (HP:0002909) | 1.81723505 |
100 | Abnormality of the sella turcica (HP:0002679) | 1.81305143 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TESK1 | 6.55369339 |
2 | VRK2 | 5.54463091 |
3 | TESK2 | 4.70248899 |
4 | NME2 | 4.64063883 |
5 | LIMK1 | 4.33820385 |
6 | ARAF | 3.38832647 |
7 | EPHA2 | 2.74563947 |
8 | MAP3K12 | 2.44667916 |
9 | PIM2 | 2.40706538 |
10 | LMTK2 | 2.01741781 |
11 | BUB1 | 1.99413715 |
12 | DAPK1 | 1.93092166 |
13 | MAP2K7 | 1.76566402 |
14 | SRPK1 | 1.62889679 |
15 | PAK4 | 1.61728675 |
16 | ABL2 | 1.57843594 |
17 | MST1R | 1.56615423 |
18 | PLK4 | 1.48591935 |
19 | IRAK3 | 1.45049601 |
20 | MAP4K2 | 1.43761169 |
21 | MOS | 1.41922464 |
22 | MYLK | 1.40205183 |
23 | CDK19 | 1.38618356 |
24 | VRK1 | 1.33204331 |
25 | NEK1 | 1.29313946 |
26 | PHKG1 | 1.26567357 |
27 | PHKG2 | 1.26567357 |
28 | KDR | 1.23195071 |
29 | BCKDK | 1.23154293 |
30 | TAOK2 | 1.16237427 |
31 | CSNK1G3 | 1.16140716 |
32 | STK16 | 1.13061760 |
33 | TAF1 | 1.09986371 |
34 | PTK2B | 1.08704301 |
35 | BRAF | 1.07641044 |
36 | ERN1 | 1.04923769 |
37 | ILK | 1.02575341 |
38 | CSNK1A1L | 1.01906706 |
39 | CDK8 | 1.01703560 |
40 | MAP3K11 | 0.96361498 |
41 | STK10 | 0.95531389 |
42 | DAPK3 | 0.91849495 |
43 | CCNB1 | 0.91092869 |
44 | ERBB4 | 0.89221938 |
45 | CSNK1G2 | 0.78254311 |
46 | AURKA | 0.73857015 |
47 | SCYL2 | 0.73389992 |
48 | CDK7 | 0.72920506 |
49 | CSNK1G1 | 0.72673732 |
50 | PAK1 | 0.70165427 |
51 | HIPK2 | 0.67852735 |
52 | MAPKAPK3 | 0.65978602 |
53 | PTK2 | 0.63967064 |
54 | EPHB2 | 0.62720150 |
55 | PDK2 | 0.61676159 |
56 | GRK5 | 0.58934233 |
57 | CDK11A | 0.54948380 |
58 | INSRR | 0.54420627 |
59 | CDK14 | 0.54391923 |
60 | MST4 | 0.53326498 |
61 | BRSK1 | 0.50072420 |
62 | TBK1 | 0.48696310 |
63 | BMX | 0.44404044 |
64 | AURKB | 0.44375680 |
65 | CDK15 | 0.43863596 |
66 | CDK18 | 0.42462420 |
67 | GRK7 | 0.41385266 |
68 | STK38 | 0.40425576 |
69 | DAPK2 | 0.40395201 |
70 | LRRK2 | 0.40225133 |
71 | ROCK1 | 0.39926392 |
72 | DDR2 | 0.39825265 |
73 | PLK1 | 0.38500868 |
74 | BMPR2 | 0.37277049 |
75 | MET | 0.35559858 |
76 | NUAK1 | 0.31187846 |
77 | RAF1 | 0.30748659 |
78 | PRKCI | 0.30526269 |
79 | CSNK2A2 | 0.30029456 |
80 | CAMK2G | 0.29411735 |
81 | MAP3K8 | 0.28005706 |
82 | ROCK2 | 0.27630163 |
83 | MAP3K3 | 0.25880366 |
84 | STK38L | 0.25072378 |
85 | TGFBR2 | 0.24723258 |
86 | TLK1 | 0.24423838 |
87 | RPS6KA5 | 0.23693660 |
88 | OXSR1 | 0.23680257 |
89 | PLK2 | 0.23265884 |
90 | CHEK2 | 0.22416317 |
91 | PLK3 | 0.20606270 |
92 | PBK | 0.19740614 |
93 | MAPKAPK2 | 0.19446403 |
94 | NEK2 | 0.18579132 |
95 | MAPK15 | 0.17981819 |
96 | CSNK2A1 | 0.16356942 |
97 | WEE1 | 0.13022967 |
98 | EIF2AK1 | 0.12885519 |
99 | CSNK1A1 | 0.12138426 |
100 | IKBKE | 0.12034895 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 5.15725369 |
2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.47203400 |
3 | Parkinsons disease_Homo sapiens_hsa05012 | 3.69131564 |
4 | DNA replication_Homo sapiens_hsa03030 | 3.60314111 |
5 | Ribosome_Homo sapiens_hsa03010 | 3.57945976 |
6 | Huntingtons disease_Homo sapiens_hsa05016 | 3.09879666 |
7 | Alzheimers disease_Homo sapiens_hsa05010 | 2.98145659 |
8 | Mismatch repair_Homo sapiens_hsa03430 | 2.82946037 |
9 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.46275748 |
10 | Base excision repair_Homo sapiens_hsa03410 | 2.45209688 |
11 | RNA polymerase_Homo sapiens_hsa03020 | 2.28784865 |
12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.18253792 |
13 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.11523254 |
14 | Homologous recombination_Homo sapiens_hsa03440 | 1.99182005 |
15 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.98894695 |
16 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.93744879 |
17 | Sulfur relay system_Homo sapiens_hsa04122 | 1.91728195 |
18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.81070354 |
19 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.56401651 |
20 | Salivary secretion_Homo sapiens_hsa04970 | 1.50642503 |
21 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.50090052 |
22 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.48349703 |
23 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.45173141 |
24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.37739717 |
25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.34656155 |
26 | Galactose metabolism_Homo sapiens_hsa00052 | 1.32986151 |
27 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.31734279 |
28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.31026529 |
29 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.30208618 |
30 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.18208369 |
31 | Protein export_Homo sapiens_hsa03060 | 1.17264125 |
32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15306081 |
33 | Purine metabolism_Homo sapiens_hsa00230 | 1.08699572 |
34 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.03452259 |
35 | Carbon metabolism_Homo sapiens_hsa01200 | 1.03262179 |
36 | Spliceosome_Homo sapiens_hsa03040 | 1.02985687 |
37 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.02884159 |
38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.99713054 |
39 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.99115727 |
40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.98615488 |
41 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.95402298 |
42 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.95369061 |
43 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.91262522 |
44 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.90207196 |
45 | RNA transport_Homo sapiens_hsa03013 | 0.80667031 |
46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79537054 |
47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.78035459 |
48 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77513936 |
49 | Metabolic pathways_Homo sapiens_hsa01100 | 0.76401223 |
50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.72910102 |
51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.72826947 |
52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.71536671 |
53 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.70962032 |
54 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.68289081 |
55 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.65901741 |
56 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65449496 |
57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.63159496 |
58 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.60526423 |
59 | Allograft rejection_Homo sapiens_hsa05330 | 0.60278911 |
60 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.58691207 |
61 | Bladder cancer_Homo sapiens_hsa05219 | 0.57552271 |
62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56945664 |
63 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55439864 |
64 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53894343 |
65 | Endocytosis_Homo sapiens_hsa04144 | 0.53081083 |
66 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51795539 |
67 | Basal transcription factors_Homo sapiens_hsa03022 | 0.47540304 |
68 | RNA degradation_Homo sapiens_hsa03018 | 0.44361988 |
69 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43841962 |
70 | Legionellosis_Homo sapiens_hsa05134 | 0.43763254 |
71 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43185337 |
72 | Shigellosis_Homo sapiens_hsa05131 | 0.41779896 |
73 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.40585882 |
74 | Cell cycle_Homo sapiens_hsa04110 | 0.39220685 |
75 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38377520 |
76 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.38226681 |
77 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.37973516 |
78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.35795167 |
79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.33490197 |
80 | Apoptosis_Homo sapiens_hsa04210 | 0.32781263 |
81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.29291205 |
82 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.29207209 |
83 | Phagosome_Homo sapiens_hsa04145 | 0.27966384 |
84 | Mineral absorption_Homo sapiens_hsa04978 | 0.27684918 |
85 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.27565829 |
86 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.26561492 |
87 | Salmonella infection_Homo sapiens_hsa05132 | 0.24786571 |
88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.22683971 |
89 | Peroxisome_Homo sapiens_hsa04146 | 0.21754562 |
90 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.21087017 |
91 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.19834315 |
92 | Lysosome_Homo sapiens_hsa04142 | 0.18411791 |
93 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.18002672 |
94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.17812831 |
95 | Asthma_Homo sapiens_hsa05310 | 0.15209559 |
96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.14511142 |
97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.12561968 |
98 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.11533565 |
99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.08694601 |
100 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.07930946 |